Fortis Healthcare Q2 FY25 PAT up 5% at Rs. 193 Cr

Hospital business revenues increase 13.9% to Rs. 1,655 crore

Fortis Hospital Mulund hosts India's first IFEM endorsed ECMO workshop for emergency medicine doctors

This two-day program was attended by 40 doctors & paramedical staff

Fortis Healthcare to divest Fortis Malar Hospital, Chennai to MGM Healthcare

The divestment is a part of Fortis' ongoing portfolio rationalization strategy

Fortis Bannerghatta conducts Karnataka's first pediatric robot-assisted surgery

The complexity of operating on a one-year-old are many with the organs being tiny, fragile

Fortis Healthcare Q1 FY24 consolidated PAT drops at Rs. 111.76 Cr

Fortis Healthcare has reported total income of Rs. 1665.55 crores during the period ended June 30, 2023

Fortis Healthcare to divest its Vadapalani, Chennai Hospital business operations to Kauvery Group of Hospitals

Astellas announces hold lifted by FDA on Fortis clinical trial of AT845

Astellas stands on the forefront of healthcare change to turn innovative science into value for patients

Fortis Healthcare posts Q1 FY2023 consolidated PAT at Rs. 122.25 Cr

The company has reported total income of Rs. 1508.55 crores during the period ended June 30, 2022.

Fortis Malar Hospitals posts Q1 FY2023 consolidated loss at Rs. 2.96 Cr

The company has reported total income of Rs. 21.73 crores during the period ended June 30, 2022.

Astellas’s update on the Fortis clinical trial of AT845 in adults for pompe disease

The FDA informed Astellas that it did not have sufficient information to assess the risks to subjects